Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Comment by Hermes8on Jun 02, 2011 8:50am
310 Views
Post# 18660960

RE: RE: One of the first movers this drill season

RE: RE: One of the first movers this drill seasonHi bywisdom.

RE: initial results from current drilling on Brewery Creek
I only know what has been publicly disclosed in the May 11 webcast. According to the webcast, we can expect the first results from Brewery Creek to come in any time now, and the remaining results from the winter drill program at Grew Creek in the next couple of weeks. We shall see. As you know, it all depends on how busy the labs are; however, the accuracy of management's estimates has been pretty good in recent times. I expect interest in the Yukon gold plays to pick up in the coming weeks. Good luck to us all.
Bullboard Posts